Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study finds

A study by the National Bureau of Economic Research found that middle-aged adults using GLP-1 drugs for obesity could save $192,735 in lifetime medical costs on average, with higher savings ($220,000) for those without college degrees. The study attributes these savings to GLP-1s' direct impact on appetite and metabolism, which benefits individuals with limited time for diet/exercise regimens.